Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Modified TGF-beta oligonucleotide for use in a method of preventing and/or treating an ophthalmic disease

Modified TGF-beta oligonucleotide for use in a method of preventing and/or treating an ophthalmic disease

US Patent 9688988 · Granted Jun 27, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-GDF15 antibody and a dosage regimen for the treatment of cancer2025
ANGPTL4 oligonucleotides influencing the regulation of the fatty acid metabolism2024
Immunosuppression-reverting oligonucleotides inhibiting the expression of CD392024
Oligonucleotide inhibiting the expression of Chop2023
ANGPTL4 oligonucleotides influencing the regulation of the fatty acid metabolism2023
Antisense oligonucleotides for inhibition of PD-L1 expression and treating cance2023
TGF-beta oligonucleotide for use in treatment of ophthalmic diseases2021
TGF-beta oligonucleotide for use in treatment of ophthalmic diseases2021
Means and methods for the treament of B cell non-hodgkin lymphoma and B cell leu2021
Multimeric oligonucleotide compounds having non-nucleotide based cleavable linke2020
Multimeric oligonucleotide compounds2020
Approach for treating inflammatory disorders2020